<DOC>
	<DOCNO>NCT02018029</DOCNO>
	<brief_summary>Cardiac resynchronization therapy ( CRT ) one last recommend treatment patient refractory symptomatic chronic heart failure reduce ejection fraction ( HFREF ) . Despite clear guideline 20 40 % implanted patient clinically ameliorate . They call `` non responder '' . Patient selection seam one key improve efficiency CRT . This protocol try assess positive predictive factor CRT multimodal approach .</brief_summary>
	<brief_title>Predictives Factors Cardiac Resynchronization Therapy : Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy Heart Failure Biomarkers</brief_title>
	<detailed_description>Cardiac resynchronization therapy ( CRT ) validate HFREF therapy . Unfortunately 20 40 % implanted patient accord guideline improvement condition . The detection `` non responder '' imperfect . The selection eligible patient cardiac resynchronization define symptomatic patient ( NYHA class II IV ) , reduce Left Ventricle ejection fraction duration leave bundle branch block . No parameter ( clinical , electrical , echocardiographical ) identify positive predictive factor cardiac resynchronization therapy . The aim investigator study identify positive predictive parameter CRT . The investigator study include patient eligible CRT accord guideline European Society Cardiology four French center ( Clermont-Ferrand , Bordeaux , Nancy , Pasteur Toulouse ) . 1 . At baseline preimplantation evaluation perform : clinical examination , laboratory assay ( biological collection ) , echocardiography-2D Strain rest stress , myocardial perfusion scintigraphy MIBG . 2 . At 6 month , response CRT primary endpoint . It composite primary endpoint , include modification : Quality Life Score ( MINNESOTA scale ) , NYHA functional status , 6-minute walk test volume leave ventricle . Three hundred patient expected period 24 month .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients 18 year 's old Patient eligible CRT accord guideline ESC 2012 : QRS ≥ 120 m LVEF ≤ 35 % appearance typical block leave arm NYHA III IV sinus rhythm , QRS ≥ 150 m LVEF ≤ 35 % non appearance block leave leg NYHA III IV sinus rhythm , QRS ≥ 130 m LVEF ≤ 30 % appearance typical LBBB NYHA II Life expectancy expect exceed one year good functional status Optimal pharmacological treatment heart failure Pregnancy Contraindications CRT Fast atrial fibrillation Taking treatment interfere bind MIBG interrupted scan Contraindications perform scan [ Hypersensitivity active substance ( 2methoxyisobutylisonitrile ( 99mTc ) Iobenguane ( 123l ) ) excipients , Pregnancy , Breastfeeding ] Contraindication achieve uncontrolled stress test [ Myocardial infarction acute recent , unstable angina , prevent ventricular ejection ( aortic stenosis , pulmonary stenosis , obstructive cardiomyopathy ) , severe hypertension , ventricular arrhythmia , case may poorly tolerate : severe anemia , respiratory insufficiency , peripheral arterial disease , inability walk cycle ... ] No affiliation French social security system Refusal participate Incapacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Cardiac Resynchronisation Therapy</keyword>
	<keyword>collagen peptide</keyword>
	<keyword>MIBG scintigraphy</keyword>
</DOC>